Preparation of a completely autologous trileaflet valve-shaped construct by in-body tissue architecture technology

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 91, Issue 2, 2009, Pages 813-818

  Nakayama, Yasuhide ^a   Yamanami, Masashi ^a,b   Yahata, Yuki ^a,c   Tajikawa, Tsutomu ^c   Ohba, Kenkichi ^c   Watanabe, Taiji ^b   Kanda, Keiichi ^b   Yaku, Hitoshi ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KANSAI UNIVERSITY   (Japan)

Author keywords

Autologous tissue; Biovalve; In body tissue architecture; In vivo tissue engineering; Trileaflet valve

Indexed keywords

ARTIFICIAL MATERIAL; AUTOLOGOUS TISSUE; BIOLOGICAL DEFENSE; BODY TISSUES; CONNECTIVE TISSUES; IN-VIVO; INNER MEMBRANES; INTERNAL SURFACES; REGENERATIVE MEDICINE; SCAFFOLD MATERIALS; TUBULAR CONSTRUCTS; TUBULAR SHAPES;

COLLAGEN; HISTOLOGY; MUSCULOSKELETAL SYSTEM; SILICONES; TISSUE;

TISSUE ENGINEERING;

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; POLYURETHAN; SILICONE; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONNECTIVE TISSUE; FIBROBLAST; HEART VALVE BIOPROSTHESIS; HISTOLOGY; IN BODY TISSUE ARCHITECTURE TECHNOLOGY; INCUBATION TIME; INFLAMMATORY CELL; MYOFIBROBLAST; NONHUMAN; REIMPLANTATION; SUBCUTANEOUS TISSUE; THICKNESS; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; ARTERIES; COLLAGEN; CONNECTIVE TISSUE; GUIDED TISSUE REGENERATION; HEART VALVES; MATERIALS TESTING; PARAFFIN EMBEDDING; POLYURETHANES; RABBITS; SILICONES;

EID: 71649090435     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31460     Document Type: Article

References (35)

1. Vongpatanasin W, Hillis D, Lange RA. Prosthetic heart valves. N Engl J Med 1996;335:407-416.
2. Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-641. (Pubitemid 24056190)
3. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. N Engl J Med 1993;328:1289-1296. (Pubitemid 23131369)
4. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med 1991;324:573-579.
5. Jamieson WRE, Munro AI, Miyagishima RT, Allen P, Burr LH, Tyers GFO. Carpentier-Edwards standard porcine bioprosthesis: Clinical performance to seventeen years. Ann Thrac Surg 1995;60:999-1007.
6. Grunkemeier GL, Jamieson WRE, Miller DC, Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac cardiovasc Surg 1994;108:709-718. (Pubitemid 24330249)
7. Chambers JB, Rajani R, Parkin D, Rimington HM, Blauth CI, Venn GE, Young CP, Roxburgh JC. Bovine pericardial versus porcine stented replacement aortic valves: Early results of a randomized comparison of the Perimount and the Mosaic valves. J Thorac Cardiovasc Surg 2008;136:1142-1148.
8. Mirsadraee S, Wilcox HE, Korossis SA, Kearney JN, Watterson KG, Fisher J, Ingham E. Development and characterization of an acellular human pericardial matrix for tissue engineering. Tissue Eng 2006;12:763-773. (Pubitemid 43726519)
9. Franklin JE, Marler JJ, Byrne MT, Melvin AJ, Clarson SJ, Melvin DB. Fiber technology for reliable repair of skeletal muscle. J Biomed Mater Res B: Appl Biomater 2008;90B:259-266.
10. Sullivan EK, Kamstock DA, Turner AS, Goldman SM, Kronengold RT. Evaluation of a flexible collagen surgical patch for reinforcement of a fascial defect: Experimental study in a sheep model. J Biomed Mater Res B: Appl Biomater 2008;87:88-94.
11. Tedder ME, Liao J, Weed B, Stabler C, Zhang H, Simionescu A, Simionescu DT. Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng A 2008;15:1257-1268.
12. Bechtel JF, Stierle U, Sievers HH. Fifty-two months' mean follow up of decellularized SynerGraft-treated pulmonary valve allografts. J Heart Valve Dis 2008;17:98-104.
13. Vincentelli A, Wautot F, Juthier F, Fouquet O, Corseaux D, Marechaux S, Le Tourneau T, Fabre O, Susen S, Van Belle E, Mouquet F, Decoene C, Prat A, Jude B. In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates? J Thorac Cardiovasc Surg 2007;134:424-432.
14. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT™ in pediatric patients. Eur J Cardio-Thorac Surg 2003;23:1002-1006. (Pubitemid 36794083)
15. Hilbert SL, Yanagida R, Souza J, Wolfinbarger L, Jones AL, Krueger P, Stearns G, Bert A, Hopkins RA. Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep. J Heart Valve Dis 2004;13:831-840.
16. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits. In vivo restoration of valve tissue. Circulation 2000;102(Suppl III):III-50-III-55.
17. Schmidt D, Mol A, Kelm JM, Hoerstup SP. In vitro heart valve tissue engineering. Methods Mol Med 2007;140:319-330.
18. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE Jr. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102 (Suppl III):III-44-III-49.
19. Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 2002;74:1438-1442. (Pubitemid 35222618)
20. Bader A, Steinhoff G, Strobl K, Schilling T, Brandes G, Mertsching H, Tsikas D, Froelich J, Haverich A. Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation 2000;70:7-14. (Pubitemid 30490745)
21. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Langer R, Vacanti JP, Mayer JE Jr. Tissue-engineered heart valve leaflets. Does cell origin affect outcome? Circulation 1997;96 (Suppl II):II-102-II-107.
22. Matsumura G, Miyagawa-Tomita S, Shin'oka T, Ikada Y, Kurosawa H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 2003;108:1729-1734.
23. Stock UA, Nagashima M, Khalil PN, Nollert GD, Herden T, Sperling JS, Moran A, Lien J, Martin DP, Schoen FJ, Vacanti JP, Mayer JE Jr. Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg 2000;119:732-740. (Pubitemid 30395470)
24. Isomatsu Y, Shin'oka T, Matsumura G, Hibino N, Konuma T, Nagatsu M, Kurosawa H. Extracardiac total cavopulmonary connection using a tissue-engineered graft. J Thorac Cardiovasc Surg 2003;126:1958-1962.
25. Hayashida K, Kanda K, Yaku H, Ando J, Nakayama Y. Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): Preparation of a prototype model. J Thorac Cardiovasc Surg 2007;134:152-159. (Pubitemid 46962064)
26. Hayashida K, Kanda K, Oie T, Okamoto Y, Ishibashi-Ueda H, Onoyama M, Tajikawa T, Ohba K, Yaku H, Nakayama Y. Architecture of an in vivo-tissue engineered autologous conduit "Biovalve." J Biomed Mater Res B: Appl Biomater 2008;86:1-8.
27. Hayashida K, Kanda K, Oie T, Okamoto Y, Sakai O, Watanabe T, Ishibashi-Ueda H, Onoyama M, Tajikawa T, Ohba K, Yaku H, Nakayama Y. "In vivo tissue-engineered" valved conduit with designed molds and laser processed scaffold. J Cardiovasc Nurs 2008;23:61-64.
28. Lee W, Park BY. The subcutaneous capsules for foreign body in fetal rabbits: Preliminary report. Yonsei Med J 2001;42:595-601. (Pubitemid 34041129)
29. Uzunismail A, Perk C, Findik H, Beyhan G, Dincler M. Effect of a fascial tissue interface on silicone implant capsule formation - A preliminary experimental study. J Plast Reconstr Aesthet Surg 2008;61:1199-1204.
30. Sakai O, Kanda K, Ishibashi-Ueda H, Takamizawa K, Ametani A, Yaku H, Nakayama Y. Development of the wing-attached rod for acceleration of "Biotube" vascular grafts fabrication in vivo. J Biomed Mater Res B: Appl Biomater 2007;83:240-247.
31. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006;12:361-365. (Pubitemid 43355087)
32. Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials Science. New York: Academic Press; 1996.
33. Zdrahala RJ, Zdrahala IJ. Biomedical applications of polyurethanes: A review of past promises, present realities, and a vibrant future. J Biomater Appl 1999;14:67-90.
34. Nakayama Y, Ishibashi-Ueda H, Takamizawa K. In vivo tissue-engineered small-caliber arterial graft prosthesis consisting of autologous tissue (biotube). Cell Transplant 2004;13:439449.
35. Watanabe T, Huang H, Hayashida K, Okamoto Y, Nemoto Y, Kanda K, Yaku H, Nakayama Y. Development of small-caliber "Biotube" vascular grafts: Preliminary animal implantation study. Artif Organs 2005;29:733.